Stock Market

Analysts still don’t seem to understand Tesla (NASDAQ:TSLA), the electric vehicle (EV) and battery maker. This is despite the fact that it is close to bringing online two new plants, one in Germany and the other in Austin, Texas. As production ramps up to meet demand, TSLA stock is bound to rise further, even though analysts haven’t raised their targets.

Source: Shutterstock

About 30 analysts have detailed forecasts for the company’s earnings according to Seeking Alpha. As an example, they expect 2022 earnings per share (EPS) to hit $7.25 per share.

So, at $688.99 on Aug. 18, that puts TSLA stock on a forward price-to-earnings (P/E) multiple of 95x. Moreover, given that it will have sales of about $68 billion in 2022 and the stock has a market cap around $682 billion, its price-to-sales (P/S) multiple is 10 times forward sales.

These high valuation metrics are why many analysts are so skittish on TSLA stock. But that is too short-sighted. Let’s look at its valuation more closely.

Valuing Tesla Stock

By 2026, after its two new plants have been in full production for at least three years, Tesla will have revenue of $198 billion and EPS of $20.82. That puts its valuation in a more reasonable light. In effect, it trades for just 3.44x 2026 forecast sales and just 33x forward earnings.

However, at least one analyst feels this is too cheap. Daniel Ives of Wedbush Securities said Tesla has “earnings power” of $20 per share. He felt that a valuation of 50 times that amount, or $1,000 per share, is an appropriate target price.

Keep in mind that this implies the company will continue to grow as more people turn to EVs instead of traditional internal combustion engine cars. There is every reason to believe that analysts are correct on this point.

Forbes points out that there are five reasons this will be the case over the next several years. One of the biggest factors is technology now that the cost of one kilowatt-hour (KwH) is below $100. Other reasons include stricter emission regulations, environmental benefits and lower costs.

In short, it seems quite reasonable that Tesla will be able to fully employ its plants and produce more than $20 per share in earnings by 2026. Therefore, it seems reasonable to value the company at 50 times earnings. This implies that at a target price of $1,000 per share, TSLA stock can see a 45% upside over the next several years.

What To Do With TSLA Stock

Right now the average of 25 analysts’ price targets according to TipRanks.com was just $701.64 as of Aug. 18, or just 1.84% above the price as of Aug. 18. Moreover, Seeking Alpha indicates that 33 sell-side analysts have an average of $685.12, which is just about at today’s price.

This puts the $1,000 target price well over the average. But it seems clear the company deserves to have a high valuation given the profits it has produced so far and the likelihood they will continue.

In situations like this, I like to use a bit of probability analysis. Let’s set the odds that other analysts are right slightly below our odds (i.e., 40% for them and 60% for our target price). As a result, we can probability-weight the two average prices and see what return that will yield.

For example, 40% times $693.38 (the average of both analyst surveys) equals a weighted price of $$277.35. And 60% times the Wedbush target price of $1,000 equals $600. So, after we add these two together, the probability-weighted average price target is $877.35.

This takes into account both price targets. It results in a potential return of 27.36%. In other words, expect to see TSLA stock rise at least 27% over the next year or so.

On the date of publication, Mark R. Hake did not hold any position in any of the securities mentioned in the article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

Mark Hake writes about personal finance on mrhake.medium.com and runs the Total Yield Value Guide which you can review here.

Articles You May Like

Trump is the most pro-stock market president in history, Wharton’s Jeremy Siegel says
Gary Gensler says he was ‘proud to serve’ as SEC chair, defends his approach to crypto regulation
Top Wall Street analysts like these dividend-paying stocks
David Einhorn to speak as the priciest market in decades gets even pricier postelection
Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value